4-Hydroxyphenylacetic acid (4-HPA) is an organic acid with the formula C8H8O3, known for its role as a biomarker in various gastrointestinal conditions and protein metabolism.
It is a metabolic product of tyrosine processed by specific Clostridia species, including Clostridioides difficile. Elevated levels of 4-HPA in urine are associated with conditions like small intestinal bacterial overgrowth (SIBO), cystic fibrosis, celiac disease, and other small bowel diseases, indicating an overgrowth of 4-HPA-producing bacteria.
Recent research highlights 4-HPA’s potential as a therapeutic agent due to its inhibitory effects on carbonic anhydrase, an enzyme crucial for regulating pH and carbon dioxide levels in the body.
By inhibiting carbonic anhydrase, 4-HPA can impact various physiological processes, including cellular respiration and metabolic pathways involved in tumor progression.
Understanding 4-HPA’s regulatory mechanisms opens new avenues for therapeutic applications in treating conditions with dysregulated carbonic anhydrase activity, such as certain cancers and metabolic disorders.
4-Hydroxyphenylacetic acid (4-HPA) is an organic acid compound with the formula C8H8O3. It is a phenolic acid that serves as a biomarker for certain gastrointestinal conditions, as well as for protein metabolism.
4-hydroxyphenylacetic acid is an endogenous derivative/metabolite of the amino acids phenylalanine and tyrosine. [13.] Disorders affecting tyrosine metabolism, such as phenylketonuria or tyrosinemia, can lead to elevated levels of 4-HPA.
Tyrosine itself is a metabolite derived from phenylalanine via the enzyme phenylalanine hydroxylase. Therefore, the metabolites derived from tyrosine, including 4-hydroxyphenylacetic acid, can be considered indirect metabolites of phenylalanine.
4-HPA is a tyrosine metabolic product of certain Clostridia bacteria species like C. difficile, C. stricklandii, and C. lituseburense. [7.] Elevated levels of 4-HPA in urine are associated with some C. dificile infections, Small intestinal bacterial overgrowth (SIBO), cystic fibrosis, celiac disease, and other small bowel diseases. [4., 6., 9.]
4-Hydroxyphenylacetic acid has also been identified as a potent inhibitor of carbonic anhydrase, an enzyme that plays a crucial role in regulating pH and carbon dioxide levels in the body. [14.]
By inhibiting carbonic anhydrase, 4-HPA can potentially interfere with the enzyme's function in various physiological processes, including the balance of bicarbonate and carbon dioxide in tissues. This inhibition can affect metabolic pathways in cells, including those involved in tumor progression and cellular respiration.
The study of 4-HPA's inhibitory effects provides insights into its potential therapeutic applications in conditions where carbonic anhydrase activity is dysregulated, such as in certain cancers and metabolic disorders.
Organic acids are organic compounds with acidic properties. They include a variety of functional groups like carboxyl, phenol, enol, and thiol, with carboxylic acids having the strongest acidity.
Organic acids are considered weak acids, with those containing phenol, enol, alcohol, or thiol groups being even weaker.
Their structures vary in terms of carbon chain types—aromatic, aliphatic, alicyclic, heterocyclic—saturation, substitutions, and the number of functional groups.
These acids play critical roles in metabolic and catabolic pathways, notably in the tricarboxylic acid cycle inside mitochondria, which is central to energy production in eukaryotes. They are also pivotal in determining the sensory properties of fruits and vegetables.
Organic acid disorders are inherited metabolic conditions that affect the enzymes or transport proteins essential for the breakdown of amino acids, lipids, or carbohydrates. They are marked by the excessive excretion of non-amino organic acids in urine, primarily due to defects in specific enzymes involved in amino acid breakdown that cause buildup of organic acids in tissues.
Conditions can manifest as inborn metabolic disorders of organic acids and amino acids, urea cycle anomalies, and mitochondrial respiratory chain deficiencies.
These disorders are typically passed down through autosomal recessive inheritance. They often present in newborns with symptoms like vomiting and lethargy, progressing to more severe neurological symptoms.
Early diagnosis and intervention are critical and can improve outcomes. Diagnostic methods include urine organic acid analysis via gas chromatography-mass spectrometry (GC/MS).
Current treatments focus on managing symptoms and preventing complications, although definitive therapies are still under research. Treatment focuses may include dietary management, detoxifying harmful metabolites, and in severe cases, organ transplantation.
Continuous monitoring and management are essential for managing symptoms and preventing complications.
Increasingly, research highlights new relationships between the microbiome and human health. Many organisms that comprise the microbiome produce organic acids that can then be tested for additional diagnostic capability.
Certain organic acids in urine like hippuric acid, benzoic acid, and indoleacetic acid are metabolites produced by gut bacteria from the breakdown of amino acids, dietary polyphenols, and other substances.
These acids provide insights into gut health and metabolic functions. For example, elevated levels of certain acids may indicate gut dysbiosis or specific metabolic imbalances, such as phenylketonuria.
Some organic acids known to be produced by the microbiome include:
Benzoic Acid (BA):
Produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Hippuric Acid (HA):
Formed in the liver by conjugation of benzoic acid with glycine. Elevated levels may indicate exposure to environmental toxins like toluene.
Phenylacetic Acid (PAA) and Phenylpropionic Acid (PPA):
These acids result from phenylalanine metabolism by gut bacteria. High urinary levels can suggest dysbiosis or disorders like phenylketonuria. PAA is also associated with depression markers.
4-Hydroxybenzoic Acid (4-HBA) and 4-Hydroxyphenylacetic Acid (4-HPAA):
Derivatives of tyrosine metabolism. 4-HBA is linked to catechin (green tea) metabolism, and 4-HPAA is useful in diagnosing small bowel diseases related to bacterial overgrowth.
3-Hydroxyphenylpropionic Acid (3-HPPA):
A metabolite from dietary polyphenols like proanthocyanidins, indicative of robust bacterial metabolism in the intestines.
3,4-Dihydroxyphenyl Propionic Acid (3,4-DHPPA):
Produced from dietary quinolones by clostridial species, with high levels suggesting an overgrowth.
3-Indoleacetic Acid (IAA): A breakdown product of tryptophan by gut bacteria such as Bifidobacterium and Bacteroides. Elevated levels are seen in conditions like phenylketonuria or dietary changes.
These organic acids are important markers in clinical diagnostics, helping to monitor metabolic disturbances, gut microbiota balance, and exposure to environmental toxins.
Their presence and concentration are influenced by diet, gut microbiota composition, and overall metabolic health, making them valuable indicators in clinical settings for assessing both metabolic and gastrointestinal conditions.
Organic Acid Testing in Functional Medicine
In functional medicine, organic acid testing is utilized to evaluate a patient's metabolic function through a simple urine test. This testing can identify metabolic imbalances that may affect a patient’s mood, energy, and overall health.
Testing provides insights into nutrient deficiencies, dietary habits, toxic exposures, and gut microbiome activity.
The results assist practitioners in customizing treatment plans to address specific metabolic dysfunctions and improve health outcomes.
Additionally, it helps in assessing the impact of microbial metabolism and the efficiency of the Krebs Cycle, aiding in personalized healthcare.
Laboratory testing for organic acids including 4-Hydroxyphenylacetic Acid is typically done in urine, although it can also be tested in blood. Testing may be ordered to diagnose an inborn metabolic disorder, or to assess metabolic function and gastrointestinal health in a functional medicine setting.
Urine samples may be collected in a clinical setting; they can also be collected at home. Some labs recommend or require a first morning void sample, to provide a concentrated sample.
Generally, falling within reference ranges for organic acids is recommended, although for many of these organic acids, a level towards the lower end of the reference range is considered optimal.
It is essential to consult with the laboratory company used for their recommended reference range for 4-Hydroxyphenylacetic Acid.
One company reports the following reference range for 4-Hydroxyphenylacetic Acid: </= 18 mmol/mol creatinine [10.]
Elevated levels of 4-Hydroxyphenylacetic Acid are associated with C. dificile infection. [7.]
It may also indicate decreased tyrosine metabolism. [11.]
Low levels of 4-Hydroxyphenylacetic Acid are not considered clinically relevant.
4-Hydroxyphenylacetic Acid is typically tested along with other organic acids to gain deeper insights into metabolic pathways and physiological processes.
Organic acids that may be tested as part of a panel include:
2-Hydroxybutyric Acid: this acid is a marker for insulin resistance and increased oxidative stress.
2-Hydroxyphenylacetic Acid: derived from phenylalanine metabolism, this acid is used as a biomarker in various metabolic assessments.
3-Hydroxybutyric Acid: a ketone body produced during fat metabolism, indicative of carbohydrate deprivation or ketogenic conditions.
3-Hydroxyisovaleric Acid: an organic acid that accumulates in leucine catabolism disorders, often elevated in maple syrup urine disease.
3-Indoleacetic Acid: a metabolite of tryptophan, it is significant in the study of serotonin pathways and plant growth regulation.
4-Hydroxybenzoic Acid: a derivative of tyrosine metabolism, it is linked to catechin (green tea) metabolism and may be produced by some intestinal bacteria.
4-Hydroxyphenylacetic Acid: a breakdown product of tyrosine, used in diagnosing disorders involving the degradation of aromatic amino acids.
5-Hydroxyindoleacetic Acid: the main metabolite of serotonin, used as a marker in the diagnosis of carcinoid syndrome.
Adipic Acid: a dicarboxylic acid that can also be formed metabolically in humans through the oxidation of certain fatty acids.
a-Keto-b-Methylvaleric Acid: an intermediate in isoleucine metabolism, which can accumulate in certain metabolic disorders.
a-Ketoisocaproic Acid: an intermediate in the metabolism of leucine, elevated in maple syrup urine disease.
a-Ketoisovaleric Acid: a breakdown product of valine metabolism, also linked to maple syrup urine disease.
a-Ketoglutaric Acid: a key intermediate in the citric acid cycle, essential for energy production and nitrogen transport.
Benzoic Acid: produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Cis-Aconitic Acid: an intermediate in the tricarboxylic acid cycle, formed by the dehydration of citric acid.
Citric Acid: a central compound in the citric acid cycle, crucial for energy production in cells.
Ethylmalonic Acid: this acid accumulates in ethylmalonic encephalopathy and is involved in fatty acid metabolism.
Fumaric Acid: an intermediate in the tricarboxylic acid (TCA) cycle, participating in energy production through its conversion to malate and subsequent participation in the generation of ATP.
Homovanillic Acid: a major metabolite of dopamine, used as a marker to monitor dopamine levels.
Hippuric Acid: formed from the conjugation of benzoic acid and glycine; elevated levels can indicate exposure to certain environmental toxins.
Hydroxymethylglutarate: an intermediate in leucine metabolism, also associated with disorders of ketogenesis and ketolysis.
Isocitric Acid: an isomer of citric acid and an important part of the citric acid cycle, pivotal in cellular energy production.
Kynurenic Acid: a product of tryptophan metabolism, known for its role as a neuroprotective agent.
Lactic Acid: produced from pyruvate via anaerobic metabolism, an indicator of hypoxia and strenuous exercise.
Malic Acid: a dicarboxylic acid found in fruits, and involved in the citric acid cycle.
Methylmalonic Acid: an indicator of Vitamin B12 deficiency, it accumulates when the vitamin is deficient.
Methylsuccinic Acid: a dicarboxylic acid often involved in alternative pathways of fatty acid metabolism.
Orotic Acid: involved in the metabolism of pyrimidines, abnormalities in its levels can indicate metabolic disorders.
Pyroglutamic Acid: an uncommon amino acid derivative that can accumulate in glutathione synthesis disorders.
Pyruvic Acid: a key intersection in several metabolic pathways; its levels are crucial for assessing cellular respiration and metabolic function.
Quinolinic Acid: a neuroactive metabolite of the kynurenine pathway, elevated levels are associated with neurodegenerative diseases.
Suberic Acid: a dicarboxylic acid that is a biomarker in adipic aciduria, often studied in relation to fatty acid oxidation disorders.
Succinic Acid: a four-carbon dicarboxylic acid that plays a central role in the Krebs cycle, crucial for energy production.
Tricarballylic Acid: an organic acid that can inhibit aconitase in the citric acid cycle and is sometimes associated with glyphosate exposure.
Vanillylmandelic Acid: a metabolite of epinephrine and norepinephrine, used as a marker for neuroblastoma and other catecholamine-secreting tumors.
Click here to compare testing options and order organic acid testing.
[1.] 4-Hydroxyphenylacetic acid | CAS 156-38-7 | SCBT - Santa Cruz Biotechnology. www.scbt.com. Accessed May 26, 2024. https://www.scbt.com/p/4-hydroxyphenylacetic-acid-156-38-7
[2.] Beley GJ, Anne M, Dadia DM. Nutrigenomics in the management and prevention of metabolic disorders. Elsevier eBooks. Published online January 1, 2023:209-274. doi:https://doi.org/10.1016/b978-0-12-824412-8.00006-0
[3.] Chahardoli A, Jalilian F, Memariani Z, Farzaei MH, Shokoohinia Y. Analysis of organic acids. Recent Advances in Natural Products Analysis. Published online 2020:767-823. doi:https://doi.org/10.1016/b978-0-12-816455-6.00026-3
[4.] Chalmers RA, Valman HB, Liberman MM. Measurement of 4-hydroxyphenylacetic aciduria as a screening test for small-bowel disease. Clin Chem. 1979 Oct;25(10):1791-4. PMID: 476929.
[5.] French D. Advances in Clinical Mass Spectrometry. Advances in Clinical Chemistry. 2017;79:153-198. doi:https://doi.org/10.1016/bs.acc.2016.09.003
[6.] Harrison, M.A., Farthing, R.J., Allen, N. et al. Identification of novel p-cresol inhibitors that reduce Clostridioides difficile’s ability to compete with species of the gut microbiome. Sci Rep 13, 9492 (2023). https://doi.org/10.1038/s41598-023-32656-8
[7.] Harrison MA, Faulds-Pain A, Kaur H, Dupuy B, Henriques AO, Martin-Verstraete I, Wren BW, Dawson LF. Clostridioides difficile para-Cresol Production Is Induced by the Precursor para-Hydroxyphenylacetate. J Bacteriol. 2020 Aug 25;202(18):e00282-20. doi: 10.1128/JB.00282-20. PMID: 32631945; PMCID: PMC7925072.
[8.] Lee YT, Huang SQ, Lin CH, Pao LH, Chiu CH. Quantification of Gut Microbiota Dysbiosis-Related Organic Acids in Human Urine Using LC-MS/MS. Molecules. 2022 Aug 23;27(17):5363. doi: 10.3390/molecules27175363. PMID: 36080134; PMCID: PMC9457824.
[9.] Maeda Y, Murakami T. Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth. Antibiotics (Basel). 2023 Jan 28;12(2):263. doi: 10.3390/antibiotics12020263. PMID: 36830173; PMCID: PMC9952535.
[10.] Rupa Health. OAT Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1lA81IDzMs3Q0myMwQR90ypXGCnFzgYGu/view
[11.] Sanchez Russo, R. Wilcox WR. Amino Acid Metabolism. Elsevier eBooks. Published online January 1, 2021:49-104. doi:https://doi.org/10.1016/b978-0-12-812535-9.00003-0
[12.] Seashore M. The Organic Acidemias: An Overview.; 2001. Accessed May 2, 2024. https://corpora.tika.apache.org/base/docs/govdocs1/141/141031.pdf
[13.] Sobolev PD, Burnakova NA, Beloborodova NV, Revelsky AI, Pautova AK. Analysis of 4-Hydroxyphenyllactic Acid and Other Diagnostically Important Metabolites of α-Amino Acids in Human Blood Serum Using a Validated and Sensitive Ultra-High-Pressure Liquid Chromatography-Tandem Mass Spectrometry Method. Metabolites. 2023 Nov 3;13(11):1128. doi: 10.3390/metabo13111128. PMID: 37999224; PMCID: PMC10673366.
[14.] Ye X, Wei X, Liao J, Chen P, Li X, Chen Y, Yang Y, Zhao Q, Sun H, Pan L, Chen G, He X, Lyu J, Fang H. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance. Front Oncol. 2021 Jan 18;10:617190. doi: 10.3389/fonc.2020.617190. PMID: 33537239; PMCID: PMC7848781.